The role of pilot studies in the economic evaluation of health technologies

International Journal of Technology Assessment in Health Care

Volumn 14, Issue 3, 1998, Pages 405-418

  Drummond, Michael ^a   Coyle, Douglas ^b  

^a UNIVERSITY OF YORK   (United Kingdom)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; BRONCHUS CANCER; CANCER RADIOTHERAPY; CLINICAL TRIAL; HEAD AND NECK CANCER; HEALTH CARE COST; HUMAN; INTERMETHOD COMPARISON; RADIATION DOSE FRACTIONATION;

EID: 0031714149     PISSN: 02664623     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0266462300011399     Document Type: Article

References (17)

1. Adams, M. E., McCall, N. T., Gray, D. T., et al. Economic analysis in randomized control trials. Medical Care, 1992, 30, 231-43.
2. Burnard, B., Kernan, W. N., & Feinstein, A. R. Indexes and boundaries for 'quantitative significance' in statistical decisions. Journal of Clinical Epidemiology, 1990, 43, 1273-84.
3. Chaudhary, M., & Stearns, S. Estimating confidence intervals for cost-effectiveness ratios: An example from a randomized trial. Statistics in Medicine, 1996, 15, 1447-58.
4. Drummond, M. F., & Davies, L. M. Economic analysis alongside clinical trials: Revisiting the methodological principles. International Journal of Technology Assessment in Health Care, 1991, 7, 561-73.
5. Drummond, M. F., & O'Brien, B. J. Clinical importance, statistical significance and the assessment of economic and quality-of-life outcomes. Health Economics, 1993, 2, 205-12.
6. Gafni, A., & Birch, S. Guidelines for the adoption of new technologies: A prescription for uncontrolled growth in expenditures and how to avoid the problem. Canadian Medical Association Journal, 1993, 148, 913-17.
7. Goddard, M., & Hutton, J. The costs of radiotherapy in cancer treatment. (CHE/YHEC Discussion Paper 48). York: Centre for Health Economics, 1988.
8. Hebert, P. C., Wells, G. A., Marshall, J. C., et al. Transfusion requirements in critical care: A pilot study. JAMA, 1995, 273, 1439-44.
9. Laupacis, A., Feeny, D., & Detsky, A. S., et al. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. Canadian Medical Association Journal, 1992, 146, 473-81.
10. Morris, J., Goddard, M., Coyle, D., & Drummond, M. F. Measuring cost and quality of life in radiotherapy treatments. CHE/YHEC Discussion Paper 112. York: Centre for Health Economics, University of York, 1993.
11. Naylor, C. D., Williams, I., Basinski, A., & Goel, V. Technology assessment and cost-effectiveness: Misguided guidelines? Canadian Medical Association Journal, 1993, 148, 921-24.
12. Netten, A., & Smart, S. Unit cost of community care 1992/93. Canterbury; Personal Social Services Research Unit, University of Kent, 1993.
13. O'Brien, B., Drummond, M. F., Labelle, R. J., & Willan, A. In search of power and significance: Issues in the design and analysis of stochastic cost-effectiveness studies in health care. Medical Care, 1994, 32, 150-63.
14. Saunders, M. I., Dishe, S., Barrett, A. et al. Randomised multicentre trials of CHART versus conventional radiotherapy in head and neck and non-small-cell lung cancer: An interim report. British Journal of Cancer, 1996, 73, 1455-62.
15. Spiegelhalter, D. J., Gore, S. M., Jones, D. R. et al. Being economical with the costs. Leicester: University of Leicester, 1996. Department of Epidemiology and Public Health Technical Report (Statistics) 96-06.
16. Torgerson, D. J., Ryan, M., & Ratcliffe, J. Economics in sample size determination for clinical trials. Quarterly Journal of Medicine, 1995, 88, 517-21.
17. van Hout, B. A., Al, M. J., Gordon, G. S., & Rutten, F. F. H. Costs, effects and C/E ratios alongside a clinical trial. Health Economics, 1994, 3, 309-19.